• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新思考精神分裂症和 2 型糖尿病共病的遗传基础。

Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes.

机构信息

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States.

出版信息

Schizophr Res. 2010 Nov;123(2-3):234-43. doi: 10.1016/j.schres.2010.08.022. Epub 2010 Sep 15.

DOI:10.1016/j.schres.2010.08.022
PMID:20832248
Abstract

The co-occurrence of schizophrenia (SCZ) and type 2 diabetes mellitus (T2D) has been well documented. This review article focuses on the hypothesis that the co-occurrence of SCZ and T2D may be, at least in part, driven by shared genetic factors. Previous genetic studies of T2D and SCZ evidence have disclosed a number of overlapped risk loci. However, the putative common genetic factors for SCZ and T2D remain inconclusive due to inconsistent findings. A systemic review of methods of identifying genetic loci contributing to the comorbidity link between SCZ and T2D is hence needed. In the current review article, we have discussed several different approaches to localizing the shared susceptibility genes for these two diseases. To begin with, one could start with probing the gene involved in both glucose and dopamine metabolisms. Additionally, hypothesis-free genome-wide association studies (GWAS) may provide more clues to the common genetic basis for these two diseases. Genetic similarities inferred from GWAS may shed some light on the genetic mechanism underlying the comorbidity link between SCZ and T2D. Meanwhile, endophenotypes (e.g., adiponectin level in T2D and working memory in SCZ) may serve as alternative phenotypes that are more directly influenced by genes than target diseases. Hence, endophenotypes of these diseases may be more tractable to identification. To summarize, novel approaches are needed to dissect the complex genetic basis of the comorbidity of SCZ and T2D.

摘要

精神分裂症(SCZ)和 2 型糖尿病(T2D)的共病现象已有充分记录。本文综述的重点是这样一种假设,即 SCZ 和 T2D 的共病可能至少部分是由共同的遗传因素驱动的。先前对 T2D 和 SCZ 证据的遗传研究揭示了许多重叠的风险位点。然而,由于研究结果不一致,SCZ 和 T2D 的潜在共同遗传因素仍不确定。因此,需要对识别 SCZ 和 T2D 共病关联中遗传位点的方法进行系统综述。在本文中,我们讨论了几种不同的方法来定位导致这两种疾病共病的共同易感基因。首先,可以从研究涉及葡萄糖和多巴胺代谢的基因开始。此外,无假设的全基因组关联研究(GWAS)可能为这两种疾病的共同遗传基础提供更多线索。从 GWAS 推断出的遗传相似性可能为 SCZ 和 T2D 共病的遗传机制提供一些启示。同时,表型(如 T2D 中的脂联素水平和 SCZ 中的工作记忆)可以作为替代表型,它们比目标疾病更直接受基因影响。因此,这些疾病的表型可能更容易识别。总之,需要新的方法来剖析 SCZ 和 T2D 共病的复杂遗传基础。

相似文献

1
Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes.重新思考精神分裂症和 2 型糖尿病共病的遗传基础。
Schizophr Res. 2010 Nov;123(2-3):234-43. doi: 10.1016/j.schres.2010.08.022. Epub 2010 Sep 15.
2
Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.精神分裂症、重度抑郁症、2 型糖尿病和代谢综合征共有的遗传因素和可能的风险基因途径部分解释了这些疾病的共病现象。
Am J Med Genet B Neuropsychiatr Genet. 2019 Apr;180(3):186-203. doi: 10.1002/ajmg.b.32712. Epub 2019 Feb 6.
3
Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia.遗传因素对精神分裂症患者 2 型糖尿病风险增加的影响证据。
Transl Psychiatry. 2018 Nov 23;8(1):252. doi: 10.1038/s41398-018-0304-6.
4
Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.多巴胺-催乳素途径可能导致精神分裂症和 2 型糖尿病共病。
Transl Psychiatry. 2016 Apr 19;6(4):e785. doi: 10.1038/tp.2016.50.
5
Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis.基于通路分析探讨精神分裂症与 2 型糖尿病的发病关联。
BMC Med Genomics. 2013;6 Suppl 1(Suppl 1):S17. doi: 10.1186/1755-8794-6-S1-S17. Epub 2013 Jan 23.
6
Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.联合治疗作为精神分裂症患者发生 2 型糖尿病的潜在风险因素:GOMAP 研究。
BMC Psychiatry. 2018 Aug 2;18(1):249. doi: 10.1186/s12888-018-1826-4.
7
Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?精神分裂症中代谢合并症的聚类:遗传因素的作用?
J Psychopharmacol. 2005 Nov;19(6 Suppl):47-55. doi: 10.1177/0269881105058380.
8
How can genetics help understand the relationship between cognitive dysfunction and schizophrenia?遗传学如何有助于理解认知功能障碍与精神分裂症之间的关系?
Scand J Psychol. 2018 Feb;59(1):26-31. doi: 10.1111/sjop.12407.
9
Modulation ofTcf7l2 expression alters behavior in mice.Tcf7l2 表达的调节改变了小鼠的行为。
PLoS One. 2011;6(10):e26897. doi: 10.1371/journal.pone.0026897. Epub 2011 Oct 27.
10
Genetic markers of type 2 diabetes: Progress in genome-wide association studies and clinical application for risk prediction.2型糖尿病的遗传标记:全基因组关联研究进展及风险预测的临床应用
J Diabetes. 2016 Jan;8(1):24-35. doi: 10.1111/1753-0407.12323. Epub 2015 Sep 15.

引用本文的文献

1
Neuronal Synaptic Communication and Mitochondrial Energetics in Human Health and Disease.人类健康与疾病中的神经元突触通讯和线粒体能量代谢
Adv Exp Med Biol. 2025;1477:105-137. doi: 10.1007/978-3-031-89525-8_5.
2
High Rates of Abnormal Glucose Metabolism Detected by 75 g Oral Glucose Tolerance Test in Major Psychiatric Patients with Normal HbA1c and Fasting Glucose Levels.在HbA1c和空腹血糖水平正常的重度精神疾病患者中,通过75克口服葡萄糖耐量试验检测到的葡萄糖代谢异常率较高。
Nutrients. 2025 Feb 8;17(4):613. doi: 10.3390/nu17040613.
3
Schizophrenia and type 2 diabetes risk: a systematic review and meta-analysis.
精神分裂症和 2 型糖尿病风险:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2024 Sep 11;15:1395771. doi: 10.3389/fendo.2024.1395771. eCollection 2024.
4
A network of transcriptomic signatures identifies novel comorbidity mechanisms between schizophrenia and somatic disorders.一个转录组特征网络识别出精神分裂症与躯体疾病之间新的共病机制。
Discov Ment Health. 2024 Apr 4;4(1):11. doi: 10.1007/s44192-024-00063-8.
5
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia.胰岛素抵抗/糖尿病与精神分裂症:潜在的共同遗传因素及对精神分裂症患者更好管理的意义
CNS Drugs. 2024 Jan;38(1):33-44. doi: 10.1007/s40263-023-01057-w. Epub 2023 Dec 14.
6
Association between polymorphism rs2421943 of the insulin-degrading enzyme and schizophrenia: Preliminary report.胰岛素降解酶 rs2421943 多态性与精神分裂症的相关性:初步报告。
J Clin Lab Anal. 2023 Jul;37(13-14):e24949. doi: 10.1002/jcla.24949. Epub 2023 Jul 28.
7
Schizophrenia polygenic risk score and type 2 diabetes onset in older adults with no schizophrenia diagnosis.精神分裂症多基因风险评分与无精神分裂症诊断的老年 2 型糖尿病发病风险。
Psychiatr Genet. 2023 Oct 1;33(5):191-201. doi: 10.1097/YPG.0000000000000349. Epub 2023 Jul 4.
8
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia.精神分裂症新兴治疗方法的代谢潜力、疗效和安全性增加。
CNS Drugs. 2023 Jul;37(7):545-570. doi: 10.1007/s40263-023-01022-7. Epub 2023 Jul 20.
9
Temporal Trends in Mortality Associated with Comorbid Type 2 Diabetes and Schizophrenia: The Fremantle Diabetes Study.2型糖尿病合并精神分裂症相关死亡率的时间趋势:弗里曼特尔糖尿病研究
J Clin Med. 2022 Dec 30;12(1):300. doi: 10.3390/jcm12010300.
10
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction.精神分裂症与代谢综合征的相互作用:催产素能功能障碍的作用。
Int J Mol Sci. 2022 Jun 25;23(13):7092. doi: 10.3390/ijms23137092.